Intravesical botulinum toxin for overactive bladder syndrome without detrusor overactivity

These preliminary, non-randomised data suggest that intravesical botulinum toxin injection may be efficacious in patients with OAB symptoms without DOA. Further evaluation by means of a randomised, controlled trial is suggested.